{
 "@context": "https://w3id.org/ro/crate/1.1/context",
 "@graph": [
  {
   "@id": "ro-crate-metadata.json",
   "@type": "CreativeWork",
   "conformsTo": {
    "@id": "https://w3id.org/ro/crate/1.1"
   },
   "about": {
    "@id": "./"
   }
  },
  {
   "@id": "./",
   "@type": "Dataset",
   "name": "RAIR-Sim: compartmental simulator of radioactive iodine therapy response in metastatic thyroid cancer (MATLAB)",
   "description": "Simulates serum thyroglobulin under a radioiodine protocol (number of sessions, interval, activity per session) for a patient profile.",
   "license": {
    "@id": "https://creativecommons.org/licenses/by/4.0/"
   },
   "datePublished": "2026-10-24",
   "author": [
    {
     "@id": "#marie-fusella-giuntini"
    },
    {
     "@id": "https://orcid.org/0000-0003-0242-7377"
    },
    {
     "@id": "#david-taieb"
    },
    {
     "@id": "#dominique-barbolosi"
    }
   ],
   "hasPart": [
    {
     "@id": "https://doi.org/10.5281/zenodo.21496197"
    },
    {
     "@id": "https://doi.org/10.1038/s41598-026-56267-1"
    },
    {
     "@id": "https://www.cyrilvoyant.com/fr/outils/modele-thyroide/"
    },
    {
     "@id": "https://www.cyrilvoyant.com/fr/recits/thyroid-radioiodine/"
    },
    {
     "@id": "https://www.cyrilvoyant.com/fr/vue-d-ensemble/"
    },
    {
     "@id": "https://www.cyrilvoyant.com/overview/"
    },
    {
     "@id": "https://www.cyrilvoyant.com/stories/thyroid-radioiodine/"
    }
   ],
   "keywords": [
    "thyroid cancer",
    "radioiodine therapy",
    "compartmental model",
    "thyroglobulin",
    "medical physics"
   ],
   "url": "https://www.cyrilvoyant.com/ro-crate/CTD_SIMU_RAI/"
  },
  {
   "@id": "https://doi.org/10.5281/zenodo.21496197",
   "@type": "SoftwareSourceCode",
   "name": "RAIR-Sim: compartmental simulator of radioactive iodine therapy response in metastatic thyroid cancer (MATLAB)",
   "license": "MIT",
   "codeRepository": "https://github.com/cyrilvoyant/CTD_SIMU_RAI",
   "programmingLanguage": "MATLAB",
   "author": [
    {
     "@id": "#marie-fusella-giuntini"
    },
    {
     "@id": "https://orcid.org/0000-0003-0242-7377"
    },
    {
     "@id": "#david-taieb"
    },
    {
     "@id": "#dominique-barbolosi"
    }
   ],
   "citation": {
    "@id": "https://doi.org/10.1038/s41598-026-56267-1"
   }
  },
  {
   "@id": "#marie-fusella-giuntini",
   "@type": "Person",
   "name": "Marie Fusella Giuntini"
  },
  {
   "@id": "https://orcid.org/0000-0003-0242-7377",
   "@type": "Person",
   "name": "Cyril Voyant"
  },
  {
   "@id": "#david-taieb",
   "@type": "Person",
   "name": "David Taieb"
  },
  {
   "@id": "#dominique-barbolosi",
   "@type": "Person",
   "name": "Dominique Barbolosi"
  },
  {
   "@id": "https://doi.org/10.1038/s41598-026-56267-1",
   "@type": "ScholarlyArticle",
   "name": "M. Fusella Giuntini, C. Voyant, D. Taieb, D. Barbolosi. A computational framework for optimizing radioiodine therapy protocols in metastatic thyroid cancer. Scientific Reports 16 (2026) 27179",
   "creativeWorkStatus": "published, open access"
  },
  {
   "@id": "https://www.cyrilvoyant.com/fr/outils/modele-thyroide/",
   "@type": "WebPage",
   "name": "www.cyrilvoyant.com/fr/outils/modele-thyroide/"
  },
  {
   "@id": "https://www.cyrilvoyant.com/fr/recits/thyroid-radioiodine/",
   "@type": "WebPage",
   "name": "www.cyrilvoyant.com/fr/recits/thyroid-radioiodine/"
  },
  {
   "@id": "https://www.cyrilvoyant.com/fr/vue-d-ensemble/",
   "@type": "WebPage",
   "name": "www.cyrilvoyant.com/fr/vue-d-ensemble/"
  },
  {
   "@id": "https://www.cyrilvoyant.com/overview/",
   "@type": "WebPage",
   "name": "www.cyrilvoyant.com/overview/"
  },
  {
   "@id": "https://www.cyrilvoyant.com/stories/thyroid-radioiodine/",
   "@type": "WebPage",
   "name": "www.cyrilvoyant.com/stories/thyroid-radioiodine/"
  }
 ]
}